Cargando…
Ivabradine Ameliorates Cardiac Function in Heart Failure with Preserved and Reduced Ejection Fraction via Upregulation of miR-133a
Heart failure (HF) is a clinical syndrome caused by impairment of ventricular filling, ejection of blood, or both and is categorized as HF with reduced ejection fraction (HFrEF) or HF with preserved ejection fraction (HFpEF) based on left ventricular function. Cardiac fibrosis contributes to left ve...
Autores principales: | Shao, Shuai, Zhang, Yue, Gong, Mengqi, Yang, Qian, Yuan, Meng, Yuan, Ming, Suo, Ya, Wang, Xinghua, Li, Ying, Bao, Qiankun, Li, Guangping |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8494584/ https://www.ncbi.nlm.nih.gov/pubmed/34630844 http://dx.doi.org/10.1155/2021/1257283 |
Ejemplares similares
-
Role of Ivabradine in Patients with Heart Failure with Preserved Ejection Fraction
por: Nadeem, Muhammad, et al.
Publicado: (2020) -
The role of Ivabradine in Diastolic Heart Failure with preserved Ejection Fraction. A Doppler-Echocardiographic study
por: Cacciapuoti, Federico, et al.
Publicado: (2017) -
The Value of IGF-1 and IGFBP-1 in Patients With Heart Failure With Reduced, Mid-range, and Preserved Ejection Fraction
por: Guo, Shaohua, et al.
Publicado: (2022) -
Effect of Ivabradine on Left Ventricular Diastolic Function of Patients With Preserved Ejection Fraction ― Results of the IVA-PEF Study ―
por: Tanaka, Hidekazu, et al.
Publicado: (2022) -
Combination of ivabradine and sacubitril/valsartan in patients with heart failure and reduced ejection fraction
por: Lee, Ying‐Hsiang, et al.
Publicado: (2021)